Journals of Gerontology Series A: Biological Sciences and Medical Sciences Large Type Edition
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]
Author:
 		Keyword(s):
Year:  Vol:  Page: 

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Google Scholar
Right arrow Articles by Pifer, J.
Right arrow Articles by Witte, P. L.
Right arrow Articles citing this Article
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pifer, J.
Right arrow Articles by Witte, P. L.
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 57:B355-B358 (2002)
© 2002 The Gerontological Society of America

Age-Related Differences in the Immune Response to Immunization With Human Aß42 Peptide

Jeannette Pifera, Jason L. Hennesa, John M. Leeb,c and Pamela L. Wittea

a Departments of Cell Biology, Neurobiology, & Anatomy,
b Pathology, Loyola University Medical Center, Maywood, Illinois
c Pharmacology, Loyola University Medical Center, Maywood, Illinois

Pamela L. Witte, Department of Cell Biology, Neurobiology, & Anatomy, Loyola University Chicago, 2160 S. First Avenue, Maywood, IL 60153 E-mail: pwitte{at}lumc.edu.

Decision Editor: James R. Smith, PhD

Several studies show that plaque burden is resolved in young to middle-aged amyloid precursor protein transgenic mice after rigorous immunization with Aß42 peptide. We determined if wild-type 20-month-old and 3-month-old animals could produce high-titer antibody against Aß42 with a less strenuous immunization protocol. All treated young animals mounted a high-titer (20,000–50,000) response after two immunizations and sustained a strong response for 6 months following the initial treatment with Aß42. However, 6 of 8 immunized aged animals did not respond after three immunizations. The 2 responding aged mice produced low-titer antibody (5,000–10,000), which rapidly declined to control levels within 5 weeks after the third immunization. Aged animals may require alternate strategies for successful vaccination, such as inclusion of stimulatory cytokines or better adjuvants. If tolerance to Aß42 underlies the poor response observed in aged animals, then a mechanism to overcome this response will have to be investigated.






HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
All GSA journals The Gerontologist
Journals of Gerontology Series B: Psychological Sciences and Social Sciences
Copyright © 2002 by The Gerontological Society of America.